|
TYRA Tyra Biosciences Inc 1863127 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-45,558,000.00 |
| Balance Sheet |
|
Current Assets
|
$366,966,000.00 |
|
Assets
|
$383,362,000.00 |
|
Current Liabilities
|
$24,620,000.00 |
|
Liabilities
|
$29,698,000.00 |
|
Equity
|
$353,664,000.00 |
|
Shares Out
|
59662877.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-63,647,000.00 |
|
Investing Cash Flow
|
$-102,390,000.00 |
| Market Analysis |
Market Cap
|
$1,532,739,310.13 |
|
Price
|
$25.69 |
|
BVPS
|
5.93 |
|
PB
|
4.33 |
|
EPS
|
-0.69 |
|
FCF
|
$-63,801,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:22 |
|
| Apr |
May |
Jun |
| 2026-03-02 |
-0.57 |
|
|
2026-05-13 |
-0.64 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.47 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.50 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TYRA documents filed with the SEC.
TYRA Filings
Clear
